Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5274790
Max Phase: Preclinical
Molecular Formula: C13H19NO4
Molecular Weight: 253.30
Associated Items:
ID: ALA5274790
Max Phase: Preclinical
Molecular Formula: C13H19NO4
Molecular Weight: 253.30
Associated Items:
Canonical SMILES: Cc1cc(=O)c(O)c(CN2CCCC(CO)C2)o1
Standard InChI: InChI=1S/C13H19NO4/c1-9-5-11(16)13(17)12(18-9)7-14-4-2-3-10(6-14)8-15/h5,10,15,17H,2-4,6-8H2,1H3
Standard InChI Key: GOAJASKYIIPTGD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 253.30 | Molecular Weight (Monoisotopic): 253.1314 | AlogP: 0.86 | #Rotatable Bonds: 3 |
Polar Surface Area: 73.91 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.43 | CX Basic pKa: 7.03 | CX LogP: 0.23 | CX LogD: 0.06 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.84 | Np Likeness Score: -0.01 |
1. He M, Fan M, Peng Z, Wang G.. (2021) An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery., 221 [PMID:34023737] [10.1016/j.ejmech.2021.113546] |
Source(1):